Cargando…
Treatment of Hypothyroid Patients With L-Thyroxine (L-T4) Plus Triiodothyronine Sulfate (T3S). A Phase II, Open-Label, Single Center, Parallel Groups Study on Therapeutic Efficacy and Tolerability
Sodium salt of levothyroxine (L-T4) is the treatment of choice of hypothyroidism. Yet, L-T4 monotherapy produces supoptimal 3,5,3′-triiodothyronine (T3)/T4 ratio in serum, as compared to normal subjects, and a minority of hypothyroid individuals on L-T4 complain for an incomplete well-being. Orally...
Autores principales: | Santini, Ferruccio, Ceccarini, Giovanni, Pelosini, Caterina, Giannetti, Monica, Ricco, Ilaria, Querci, Giorgia, Grossi, Enzo, Saponati, Giorgio, Vitti, Paolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6896827/ https://www.ncbi.nlm.nih.gov/pubmed/31849843 http://dx.doi.org/10.3389/fendo.2019.00826 |
Ejemplares similares
-
Free triiodothyronine/free thyroxine ratio in children with congenital hypothyroidism
por: Sydlik, Carmen, et al.
Publicado: (2022) -
Diagnostic Values of Free Triiodothyronine and Free Thyroxine and the Ratio of Free Triiodothyronine to Free Thyroxine in Thyrotoxicosis
por: Chen, Xinxin, et al.
Publicado: (2018) -
Associations among Ratio of Free Triiodothyronine to Free Thyroxine, Chronic Kidney Disease, and Subclinical Hypothyroidism
por: Shimizu, Yuji, et al.
Publicado: (2022) -
LDL-cholesterol lowering effect of a new dietary supplement: an open label, controlled, randomized, cross-over clinical trial in patients with mild-to-moderate hypercholesterolemia
por: Magno, S., et al.
Publicado: (2018) -
Relation of Gut Microbes and L-Thyroxine Through Altered Thyroxine Metabolism in Subclinical Hypothyroidism Subjects
por: Yao, Zhenyu, et al.
Publicado: (2020)